CLARUS THERAPEUTICS HOLDINGS, INC. Share-based Payment Arrangement, Expense
CLARUS THERAPEUTICS HOLDINGS, INC. reported Share-based Payment Arrangement, Expense of $451.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2022-08-19
- CLARUS THERAPEUTICS HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2022-06-30 was $451.00K, a 154.80% increase year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2022-03-31 was $432.00K, a 145.45% increase year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2021-12-31 was $109.00K, a 81.56% decline year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. share-based payment arrangement, expense for the quarter ending 2021-09-30 was $207.00K, a 130.00% increase year-over-year.
- CLARUS THERAPEUTICS HOLDINGS, INC. share-based payment arrangement, expense for fiscal 2021 was $668.00K, a 19.03% decline from fiscal 2020.
- CLARUS THERAPEUTICS HOLDINGS, INC. share-based payment arrangement, expense for fiscal 2020 was $825.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2022-06-30 | $451.00K 10-Q · filed 2022-08-19 | $883.00K 10-Q · filed 2022-08-19 | $992.00K derived: sum of 3 quarters · filed 2022-08-19 | $1.20M derived: sum of 4 quarters · filed 2022-08-19 |
| 2022-03-31 | $432.00K 10-Q · filed 2022-05-16 | $541.00K derived: sum of 2 quarters · filed 2022-05-16 | $748.00K derived: sum of 3 quarters · filed 2022-05-16 | $925.00K derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $316.00K derived: sum of 2 quarters · filed 2022-03-31 | $493.00K derived: sum of 3 quarters · filed 2022-08-19 | $668.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | $207.00K 10-Q · filed 2021-11-19 | $384.00K derived: sum of 2 quarters · filed 2022-08-19 | $559.00K 10-Q · filed 2021-11-19 | $1.15M derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-06-30 | $177.00K 10-Q · filed 2022-08-19 | $353.00K 10-Q · filed 2022-08-19 | $944.00K derived: sum of 3 quarters · filed 2022-08-19 | $1.03M derived: sum of 4 quarters · filed 2022-08-19 |
| 2021-03-31 | $176.00K 10-Q · filed 2022-05-16 | $767.00K derived: sum of 2 quarters · filed 2022-05-16 | $857.00K derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $591.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $681.00K derived: sum of 2 quarters · filed 2022-03-31 | $825.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $90.00K 10-Q · filed 2021-11-19 | $234.00K 10-Q · filed 2021-11-19 |